AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells

Journal: Nature Communications

Published: 2019-01-16

DOI: 10.1038/s41467-018-08074-0

Affiliations: 12

Authors: 24

Go to article
Institutions FC
Division of Medical Oncology, KU, Japan 0.27
Graduate School of Medical Sciences, KPUM, Japan 0.19
Graduate School of Biomedical Sciences, Nagasaki University, Japan 0.10
National Cancer Institute (INCA), Brazil 0.08
Graduate School of Medical and Dental Science (MDS), Niigata University, Japan 0.08
Niigata Cancer Center Hospital, Japan 0.08
Kyoto First Red Cross Hospital, Japan 0.04
Department of Thoracic, Cardiovascular and General Surgery, Kanazawa University, Japan 0.04
Japanese Red Cross Nagasaki Atomic Bomb Hospital, Japan 0.04
Graduate School of Biomedical Sciences, Tokushima University, Japan 0.04
WPI Nano Life Science Institute (NanoLSI), KU, Japan 0.02

Return

Except where otherwise noted © 2019 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER